logo-loader

Mariana Resources assesses potential of second Turkey asset

Published: 03:04 29 Nov 2016 EST

MineRig
Drilling is underway in Turkey - on a new property.

Hard on the heels of the success enjoyed in Turkey at the high-grade Hot Maden gold project, Mariana Resources (LON:MARL, TSE:MRY) has begun a modest drill programme on a second asset in the country.

It is the Ergama copper-gold property in Balikesir Province. Its potential is being assessed by sinking initial seven-holes.

The main targets are a near-surface, porphyry-style copper-gold mineralisation within the central portion of the block and high grade gold-silver mineralisation.

Work is expected to be complete by the end of January with the assay results scheduled sometime in the first quarter.

Ergama, which is wholly owned by Mariana, covers almost 2,200 hectares of western Turkey between a highly mineralised area called the Biga Pensinsula and Eldorado Gold's Kisladag mine.

The latter is the country’s biggest gold mine, churning out 280,000 ounces of the yellow metal a year.

Geological mapping at Ergama has identified zones of what Mariana’s geologists believe are both porphyry and epithermal-style deposits.

“Ergama is a 100% owned, prospective, copper-gold porphyry target in a region that hosts a number of key discoveries, development projects and mines and Turkey's largest gold mine Kisladag operated by Eldorado Gold,” said Mariana chief executive Glen Parsons.

"Mariana's objective is to confirm mineralisation and geological model being a mineralised copper gold porphyry system as well as high grade gold and silver epithermal mineralisation and, if successful, will lead to the next stage of drilling at Ergama.”

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

49 minutes ago